Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00129389
What this trial is testing

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 1,925
Early research (Phase 1)Study completedNCT00050167
What this trial is testing

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 603
Not applicableLooking for participantsNCT06830590
What this trial is testing

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Who this might be right for
Breast CancerMolecular Pathway DeregulationTreatment
Liaquat University of Medical & Health Sciences 300
Early research (Phase 1)Study completedNCT01133912
What this trial is testing

Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

Who this might be right for
Breast Cancer
Jungsil Ro 13
Not applicableLooking for participantsNCT04562623
What this trial is testing

Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma

Who this might be right for
Ovarian CarcinomaBreast Carcinoma
Centre Leon Berard 160
Very early researchStudy completedNCT04857697
What this trial is testing

Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
Mayo Clinic 6
Large-scale testing (Phase 3)Ended earlyNCT00010153
What this trial is testing

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT01763931
What this trial is testing

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Testing effectiveness (Phase 2)Study completedNCT04664972
What this trial is testing

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Who this might be right for
Triple Negative Breast Cancer
Henan Cancer Hospital 212
Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844
What this trial is testing

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

Who this might be right for
Breast Cancer
Stephen Shiao 66
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Testing effectiveness (Phase 2)WithdrawnNCT00855114
What this trial is testing

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota
Not applicableActive Not RecruitingNCT02161900
What this trial is testing

Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer

Who this might be right for
Non Metastatic Operable Breast Cancer
Tata Memorial Hospital 850
Not applicableUnknownNCT04985253
What this trial is testing

Correlation of Predictive Accuracy of PREDICT Version 2.2 of Indian Women With Operable Breast Cancer

Who this might be right for
Operable Breast Neoplasms
Tata Memorial Centre 2,780
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Large-scale testing (Phase 3)Study completedNCT02468739
What this trial is testing

Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 206
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Large-scale testing (Phase 3)Ended earlyNCT03498716
What this trial is testing

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Hoffmann-La Roche 2,199
Large-scale testing (Phase 3)Active Not RecruitingNCT02221999
What this trial is testing

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 250
Not applicableUnknownNCT01592825
What this trial is testing

PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors

Who this might be right for
Breast Cancer
Martin-Luther-Universität Halle-Wittenberg 1,000
Next Page